Univest Financial Corp Amgen Inc Transaction History

Univest Financial Corp

  • $356 Million
  • Q2 2024

A detailed history of Univest Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Univest Financial Corp holds 1,383 shares of AMGN stock, worth $443,334. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,383
Previous 1,428 3.15%
Holding current value
$443,334
Previous $406,000 6.4%
% of portfolio
0.12%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
SELL
$262.75 - $319.31 $11,823 - $14,368
-45 Reduced 3.15%
1,383 $432,000
Q1 2024

May 08, 2024
SELL
$268.87 - $324.56 $38,986 - $47,061
-145 Reduced 9.22%
1,428 $406,000
Q4 2023

Feb 06, 2024
SELL
$255.7 - $288.46 $13,807 - $15,576
-54 Reduced 3.32%
1,573 $453,000
Q3 2023

Nov 07, 2023
SELL
$218.65 - $271.46 $150,212 - $186,493
-687 Reduced 29.69%
1,627 $437,000
Q2 2023

Aug 07, 2023
SELL
$214.27 - $253.37 $4.41 Million - $5.22 Million
-20,594 Reduced 89.9%
2,314 $513,000
Q1 2023

May 08, 2023
BUY
$225.79 - $275.2 $1.65 Million - $2.02 Million
7,325 Added 47.01%
22,908 $5.54 Million
Q4 2022

Feb 09, 2023
SELL
$229.03 - $291.01 $553,794 - $703,662
-2,418 Reduced 13.43%
15,583 $4.09 Million
Q3 2022

Nov 03, 2022
SELL
$224.46 - $253.15 $1.57 Million - $1.77 Million
-6,993 Reduced 27.98%
18,001 $4.06 Million
Q2 2022

Aug 05, 2022
SELL
$230.71 - $256.74 $81,902 - $91,142
-355 Reduced 1.4%
24,994 $6.08 Million
Q1 2022

May 05, 2022
BUY
$219.27 - $242.57 $77,183 - $85,384
352 Added 1.41%
25,349 $6.13 Million
Q4 2021

Feb 08, 2022
SELL
$198.88 - $227.6 $13,523 - $15,476
-68 Reduced 0.27%
24,997 $5.62 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $236,893 - $277,549
1,116 Added 4.66%
25,065 $5.33 Million
Q2 2021

Jul 20, 2021
SELL
$233.58 - $259.14 $211,389 - $234,521
-905 Reduced 3.64%
23,949 $5.84 Million
Q1 2021

Apr 14, 2021
SELL
$221.91 - $258.6 $21,969 - $25,601
-99 Reduced 0.4%
24,854 $6.18 Million
Q4 2020

Jan 19, 2021
BUY
$216.38 - $257.67 $228,280 - $271,841
1,055 Added 4.41%
24,953 $5.74 Million
Q3 2020

Oct 13, 2020
SELL
$234.65 - $260.95 $217,051 - $241,378
-925 Reduced 3.73%
23,898 $6.07 Million
Q2 2020

Jul 09, 2020
SELL
$197.81 - $242.74 $53,606 - $65,782
-271 Reduced 1.08%
24,823 $5.86 Million
Q1 2020

May 05, 2020
BUY
$182.24 - $241.7 $405,301 - $537,540
2,224 Added 9.72%
25,094 $5.09 Million
Q4 2019

Jan 14, 2020
SELL
$189.21 - $243.2 $216,645 - $278,464
-1,145 Reduced 4.77%
22,870 $3.34 Million
Q3 2019

Nov 06, 2019
SELL
$174.11 - $208.62 $61,112 - $73,225
-351 Reduced 1.44%
24,015 $4.65 Million
Q2 2019

Jul 12, 2019
BUY
$166.7 - $195.41 $75,515 - $88,520
453 Added 1.89%
24,366 $4.49 Million
Q1 2019

Apr 09, 2019
BUY
$180.87 - $203.88 $66,741 - $75,231
369 Added 1.57%
23,913 $4.54 Million
Q4 2018

Jan 28, 2019
BUY
$178.4 - $208.25 $63,332 - $73,928
355 Added 1.53%
23,544 $4.58 Million
Q3 2018

Oct 10, 2018
SELL
$185.29 - $208.89 $126,923 - $143,089
-685 Reduced 2.87%
23,189 $4.81 Million
Q2 2018

Jul 17, 2018
SELL
$166.05 - $186.51 $133,172 - $149,581
-802 Reduced 3.25%
23,874 $4.41 Million
Q1 2018

Apr 19, 2018
SELL
$169.43 - $198.0 $120,634 - $140,976
-712 Reduced 2.8%
24,676 $4.21 Million
Q4 2017

Jan 22, 2018
BUY
$168.79 - $188.59 $101,274 - $113,154
600 Added 2.42%
25,388 $4.42 Million
Q3 2017

Oct 13, 2017
BUY
$167.29 - $191.0 $4.15 Million - $4.73 Million
24,788
24,788 $4.62 Million

Others Institutions Holding AMGN

# of Institutions
3,052
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Univest Financial Corp Portfolio

Follow Univest Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Univest Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Univest Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email